Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- BioVittoria's PureLo® Luo Han Fruit-Based Sweetener Obtains GRAS Affirmation
PureLo®, the company's proprietary Luo Han fruit concentrate, has been affirmed as a GRAS (Generally Regarded As Safe) food ingredient enabling its use in a variety of foods and beverages as a sweetener and flavor modifier.
- Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries
Company introduces low molecular weight hyaluronic acid.
- Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries
Company introduces low molecular weight hyaluronic acid.
- Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries
Company introduces low molecular weight hyaluronic acid.
- Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries
Company introduces low molecular weight hyaluronic acid.
- Cactus Botanics Announces Low Molecular Weight Hyaluronic Acid For Food and Cosmetic Industries
Company introduces low molecular weight hyaluronic acid.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Omega-3 Partnership Between Fjordlaks and Borregaard
Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Next Pharmaceuticals Announces New Delivery Form for Relora®
Company announces that a microencapsulated concentrate version of the ingredient Relora® is now available.
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Phase 2 White Bean Extract Receives GRAS Status
Company's branded white bean extract, Phase 2 Starch Neutralizer®, has been designated “generally recognized as safe,” (GRAS).
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- Effective, Safe, Doctor-Recommended DiosVein(TM) from Europe Addresses Vein Conditions
Berg Imports offers DiosVein(TM), bioflavanoid-rich and derived from Sweet Orange, made from the supplement diosmin, targeted at promoting healthy circulation.
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- 7-Keto® from Humanetics is Part of Fat-burning Matrix Technology Behind Anadrox™ From MHP
MHP (Maximum Human Performance) recently introduced Anadrox(TM), a combination muscle growth/fat burning product which contains 7-Keto®, a branded ingredient from Humanetics Corporation
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- China’s First Yogurt Drink Launched With EPA And DHA From Fish Oil
Company announces the launch of China’s first drinkable yogurt, OMU brand drinkable yogurt, enriched with MEG-3® brand Omega-3 EPA/DHA made from fish oil.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance
Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
Green Bay, WI (June 1, 2006) -- French scientists have discovered a revolution in Omega-3 supplements, and EuroPharma is bringing it to the US market. EuroPharma has entered into an exclusive North American distribution agreement for Vectomega®, a natural marine complex made up of five different phospholipids, DHA and EPA, along with proteins and amino acids as they occur in nature.
Omega 3 fish oils have become increasingly popular in response to a growing body of science on its health benefits. Vectomega® uses a biological innovation that extracts naturally occurring marine phospholipids with the omega-3 fatty acids, EPA and DHA. Other fish oil products do not contain these marine phospholipids. This patented innovation, called vectorization, uses a gentle, cold water and enzyme process avoiding heat, solvents, and chemical modifications that are utilized to process all other fish oils.
Vectomega’s® phospholipid vectorization has been clinically demonstrated to have superior bioavailability compared to other fish oils. In technical terms, the amphiphilic properties of the marine phospholipids can easily cross the hydrophilic membrane barriers for superior bioabsorption compared to “neutrally charged” commercial fish oils on the market today. Research has confirmed that 50 times more Vectomega® DHA and EPA crosses the cell membrane as compared to standard commercial fish oil products.
At the therapeutic dose, 2 tablets (600 mg) of Vectomega® are equal to 16 capsules (7,200 mg) of standard fish oil. Research has shown that because the marine phospholipids contain DHA and EPA in a specific location on the carbon chain (Sn-2 on the glycerol), Vectomega® is 50 times more absorbable via cell membranes.
“There is vast scientific data supporting the benefits of fish oil and its impact on the quality of health, including cardiovascular, cognitive function, joint mobility, anti-inflammatory action, improved liver function, vision and auditory health, cholesterol lowering including LDL levels, and anti-depressant properties,” stated Terry Lemerond, president of EuroPharma. “Vectomega® surpasses other fish oil products in terms of bioavailability, absorption and efficacy. The addition of Vectomega® to any commercial application will dramatically re-position any food product into a health product, thus increasing its market potential.”
This new marine phospholipid omega-3 supplement is available in dry water soluble powder, ideal for many functional food applications (milk drinks, infant formulas, other beverages, soups, sauces, salad dressings, frozen prepared meals, pastas, spreads, yogurts, cheeses, egg substitutes and nutrition bars) and dietary supplement formulation applications (tablets, capsules).
For more information, availability and pricing, visit www.EuroPharmaUSA.com or contact Lisa Joski, Ljoski@EuroPharmaUSA.com, 920-406-6500.
Located in Green Bay, Wisconsin, EuroPharma, Inc., is committed to discovering innovative products that have been extensively researched and demonstrated to be safe, natural and effective which will help people live healthier and more fulfilling lives. EuroPharma’s mission is to bring truly unique and industry changing products to the U.S. marketplace. EuroPharma is an extension of its founder, Terry Lemerond’s historic successes and a proven model of product development.
- END - |